2015 MDEA Finalists: Corindus CorPath 200

Corindus CorPath 200

May 1, 2015

1 Min Read
MDDI logo in a gray background | MDDI

The Corindus CorPath 200 system, manufactured by Corindus Vascular Robotics (United States), is the first FDA-cleared system for robotic-assisted percutaneous coronary intervention procedures; it helps optimize clinical outcomes while protecting interventional cardiologists from radiation exposure during procedures.

Supply/design credit: Farm Design Inc.  

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like